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Abstract 
Background: The detection of perineural invasion (PNI) by carcinoma in prostate biopsies 
has been shown to be associated with poor prognosis. The assessment and quantification of 
PNI is; however, labor intensive. In the study we aimed to develop an algorithm based on 
deep neural networks to aid pathologists in this task. 
Methods: We collected, digitized and pixel-wise annotated the PNI findings in each of the 
approximately 80,000 biopsy cores from the 7,406 men who underwent biopsy in the 
prospective and diagnostic STHLM3 trial between 2012 and 2014. In total, 485 biopsy cores 
showed PNI. We also digitized more than 10% (n=8,318) of the PNI negative biopsy cores. 
Digitized biopsies from a random selection of 80% of the men were used to build deep 
neural networks, and the remaining 20% were used to evaluate the performance of the 
algorithm.  
Results: For the detection of PNI in prostate biopsy cores the network had an estimated 
area under the receiver operating characteristics curve of 0.98 (95% CI 0.97-0.99) based on 
106 PNI positive cores and 1,652 PNI negative cores in the independent test set. For the 
pre-specified operating point this translates to sensitivity of 0.87 and specificity of 0.97. The 
corresponding positive and negative predictive values were 0.67 and 0.99, respectively. For 
localizing the regions of PNI within a slide we estimated an average intersection over union 
of 0.50 (CI: 0.46-0.55). 
Conclusion: We have developed an algorithm based on deep neural networks for detecting 
PNI in prostate biopsies with apparently acceptable diagnostic properties. These algorithms 
have the potential to aid pathologists in the day-to-day work by drastically reducing the 
number of biopsy cores that need to be assessed for PNI and by highlighting regions of 
diagnostic interest.  
Introduction 
The identification of perineural invasion (PNI) by prostate carcinoma in prostate biopsies has 
been shown to be associated with poor outcomes.1,2 In the United States each year 
approximately one million men undergo prostate biopsy and in various series PNI ranges 
from 7% to 33% of cases.2,3 The intuitive reason for the poorer prognosis of men with PNI is 
that the cancer has invaded the perineural space of at least one nerve and it is via this route 
that tumor is able to spread outside the prostate. Despite increasing evidence of the 
prognostic significance of PNI, pathology reporting guidelines have so far not included PNI 
as a mandatory reporting element, although recently it has been included in prognostic 
guidelines for urologists4,5  
 
A possible reason for PNI not being included in prostate pathology reporting guidelines may 
be that results from early studies regarding the prognostic significance of PNI were 
contradictory.6 As a result it would seem a reasonable conclusion that the reporting of PNI 
could not be justified.7 More recent studies have indicated that the identification of PNI is of 
prognostic significance and there is a growing body of evidence to suggest that PNI should 
be routinely reported in prostate biopsies.6 
 
Workload issues are an on-going problem in pathology. Internationally the number of 
pathologists in clinical practice is in decline, while the breadth and complexity of pathology 
reporting is increasing. This is especially so in the case of prostate biopsies as the incidence 
of prostate cancer is increasing due to an increasing demand for informal/opportunistic 
screening for prostate cancer in an aging population. The workload issue is further 
compounded by the increasing number of biopsy cores that are taken as part of random 
sampling of the prostate for cancer. Similarly increasing numbers of cores are submitted 
from targeted biopsies that are designed to both diagnose and delineate the extent of 
malignancy. It is for this reason that recent initiatives have resulted in the development of 
artificial intelligence (AI) systems that have been designed to screen for cancer. The 
expectation here is that these will facilitate cancer diagnosis and assist pathologists in the 
routine screening of prostate cancer biopsies.8 
 
Recently, two studies have demonstrated AI systems utilizing deep neural networks (DNN) 
to perform equivalently to expert uro-pathologists in grading prostate biopsies.9,10 These 
networks have been trained through the screening of thousands of sections of both benign 
and malignant biopsies, including a variety of cancer morphologies. In these series cancers 
were diagnosed in foci of PNI; however, a drawback with these current networks is that they 
lack the capability to distinguish between PNI and invasive cancer. While PNI will be 
recognized as a malignant focus its true nature is overlooked, which means that potentially 
useful prognostic information is lost. In view of this it is apparent that if AI is to have a role in 
prostate cancer diagnosis there is a need for networks to be built that explicitly target 
relevant pathological features. Despite the obvious need to expand the role of AI systems in 
the diagnosis of prostate cancer, to the best of our knowledge, there are no studies that 
have examined the utility of using AI to target PNI.  
 This study is based upon a large series of prostate cancer biopsies accessioned 
prospectively as part of a trial to develop DNNs for the diagnosis of prostate cancer.11,12 
Specifically, we have utilized a subset of cases to develop and validate the automatic 
detection of PNI in prostate biopsies, with the aim of demonstrating clinically useful 
diagnostic properties. 
Methods 
Study design and participants 
This study is based upon biopsy cores from men who participated in the STHLM3 trial 
(ISRCTN84445406). This was a prospective and population-based trial designed to evaluate 
a diagnostic model for prostate cancer. Patients in the trial were aged between 50 to 60 
years and cases were accrued between May 28, 2012, and December 30, 2014. Formal 
diagnosis of prostate cancer was by 10-12 core transrectal ultrasound guided systematic 
biopsies.  
Slide preparation and digitization  
The biopsy cores were formalin fixed, stained with haematoxylin and eosin and mounted on 
glass slides. Histologic assessment was undertaken by the study pathologist (LE) and 
pathological features including cancer grade and PNI were entered into a database. We then 
randomly selected 1,427 participants from which we retrieved 8,803 biopsy cores. The 
selection was stratified by grade to include a larger sample of high-grade cancers and all 
cases containing PNI (see Fig. 1 and Supplementary Appendix 1). From these, we randomly 
assigned 20% of the subjects to a test set to evaluate PNI. 
Slide annotations 
Each slide containing PNI was re-assessed digitally by the study pathologist (LE) and all 
regions of PNI were annotated pixel-wise using QuPath.13 In total there were 485 slides that 
contained at least one cancer with associated PNI. Binary masks of the slides were 
generated, and they acted as pixel-wise ground truth labels for training and validation 
purposes (see Supplementary Appendix 1). 
Deep neural networks 
Patch extraction 
To train the DNNs on PNI morphology we extracted patches from each of the slides. Patch 
size was approximately 0.25 mm x 0.25 mm (see Supplementary Appendix 3), which was 
large enough to cover the size and shape of most of the nerves which showed infiltration by 
cancer. We evaluated different patch sizes within the training data with slightly lower 
performance (see Supplementary Appendix 4). To learn pixel-wise prediction we also 
extracted the corresponding region from the binary masks which acted as labels. 
Network architecture 
Convolutional DNNs were used to classify patches (Xception) and to identify the regions in 
the biopsy where PNI was present (Unet).14,15 
 
For classification, we used soft voting (i.e. averaging probabilities) from an ensemble of 10 
networks to generate final patch wise probabilities. The highest probability for PNI among 
patches from a single core was used as a prediction score for classifying a core as PNI 
positive or negative at different operating points. Similarly, we used the highest predicted 
patch within a subject for subject-level classification. 
 
For segmentation, i.e. pixel-wise prediction to identify the exact regions on each slide where 
the PNI was located, we first obtained pixel-wise predictions for each patch. We then re-
mapped the predictions to the location from which each patch was extracted. We applied 
pixel-wise averaging across the slide for pixels with overlapping patches, and over all 
networks in the ensemble to generate probabilities for each pixel to contain PNI. Finally, we 
used an a priori specified threshold to classify each pixel in the slide as PNI positive or 
negative (see Supplementary Appendix 3).  
Statistical analysis 
The receiver operating characteristic (ROC) curve and the area under the ROC curve (AUC) 
were used to evaluate the performance of the algorithm. In addition, we analyzed four pre-
specified operating points (the index test and three alternative positivity criteria) on which we 
have reported sensitivity, specificity, positive predictive value (PPV), negative predictive 
value (NPV), and accuracy. For evaluating pixel-wise segmentation, we used intersection 
over union (IoU). Specifically, we used all predicted positive and true positive pixels for each 
core to measure the core wise IoU, and then reported the average of these IoUs across all 
PNI positive cores. All analyses (except IoU) were done both at individual core level and at 
subject level. 
 
All confidence intervals (CIs) were two-sided with 95% confidence levels calculated from 
1000 bootstrap samples. The networks and all analyses were implemented in Python 
(version 3.6.5) and TensorFlow (version 2.0.0).16 For the Unet implementation we used the 
Python package segmentation_models with focal loss.17 
Results 
In this study of 1,427 subjects 266 (18.6%) were positive for PNI. The PNI positive men 
generally had higher serum prostate specific antigen (PSA) levels prior to biopsy, were more 
likely to have positive findings on digital rectal examination and had cancers that were larger 
and of higher grade (see Table 1). From these subjects 8,803 slides were examined, of 
which 485 (5.5%) were positive for PNI. 
 
The AUC for discriminating between PNI positive and negative was 0.98 (CI: 0.97-0.99) for 
individual slides (PNI positive = 106, PNI negative = 1,652), and 0.97 (CI: 0.93 - 0.99) for 
subjects (PNI positive = 52, PNI negative = 234), (Fig. 2). Sensitivity and specificity, positive 
and negative predictive values, and accuracy at the index test’s operating point and three 
alternative operating points are shown in Table 2, both at the level of individual cores and at 
a subject level.  
 
The estimated mean IoU across slides was 0.50 (CI: 0.46-0.55), which measures pixel-wise 
agreement between the study pathologist’s annotation of PNI and the pixels classified as 
positive by the algorithm. For reference, Fig. 3 shows the individual PNI positive slide in the 
test set with IoU closest to the mean IoU.  
 
Discussion 
 
Even though the propensity of prostate cancer to invade perineural spaces is well known, it 
is only comparatively recently that it has been shown to be independently associated with 
poor outcome. The presence of PNI appears to be of more prognostic significance when 
detected in biopsies and in accordance with this, urology practice guidelines support the 
reporting of PNI. Since the assessment of needle biopsies for the presence of PNI biopsies 
is tedious there is well recognized inter-observer error, which itself may have contributed to 
the confusion relating to the prognostic significance of PNI. Currently, pathology reporting 
guidelines, issued by both international bodies and jurisdictional pathology authorities, do 
not include PNI as a required element.18–20 In view of the increasing evidence of the utility of 
PNI detection as a prognostic parameter this is likely to change.21 In some cases 
identification of PNI may be problematic, with foci of infiltration of the perineural space being 
difficult to distinguish from stromal bundles or collagenous micronodules situated adjacent to 
malignant glands. In this context DNNs may assist in the detection of PNI as they appear to 
reach a more consistent level of performance when compared to the subjective observations 
of diagnostic pathologists. Since DNNs are consistent in their decisions and are easily 
distributed, they also have potential value as a teaching tool. 
 
In this study we have demonstrated a novel deep learning system which we have shown to 
detect PNI in prostate cancer biopsies with high AUC. Use of the system may also assist 
pathologists by suggesting regions of interest for PNI in a biopsy slide. We believe that with 
the addition of further cases the diagnostic specificity of the reporting system can be further 
improved. Specifically, additional cases would permit further calibration of the system to 
more accurately handle difficult cases based on the diagnostic input from expert 
pathologists. 
 
The main strength of this study is that we have identified, digitized and annotated all foci of 
PNI in each of more than 80,000 biopsy cores from all men who underwent biopsy as part of 
the STHLM3 trial. Since this trial was based upon a randomized population-based selection 
of men, there is a strong probability that the tumors sampled have displayed a broad 
spectrum of morphologies. This in turn suggests that the results may be generalized, and the 
diagnostic algorithms developed in this study are applicable to other populations. Further 
strengths of the study are that our reporting network was validated by a large independent 
test set and that the pathology of all the cases in the series was evaluated and reported by a 
single specialist prostate pathologist.  
 
The main limitation of the study is that, due to the high cost of digitizing the samples, we 
could not include biopsies from all the subjects that participated in the STHLM3 trial in this 
PNI study. We felt that this was untenable due to the relatively low value that would have 
been added to the study by including all the numerous cores with no tumor and those with 
low grade cancers.  
 
The selection of cases for study was random but cases were stratified by grade to include 
sufficient high-grade cancers in the series. This was considered necessary as high-grade 
prostate cancers are only infrequently encountered in screening trials. This makes it difficult 
to interpret the predictive values, which depend on the prevalence of positive and negative 
cases. For example, if we had not over-sampled positive cases the already high NPV would 
likely be even higher and the somewhat low PPV would likely be even lower. Even if the 
PPV appears low – as approximately half of the predicted positive slides do not contain PNI 
– it should be noted that in the series PNI was not present in most cases. Despite this, only 
assessing the slides which were predicted as positive would result in a substantial reduction 
in work for the reporting pathologist. Importantly, the AUCs (sensitivity and specificity) were 
not confounded by artificial oversampling of positive cases. 
 
Another limitation in the study was a difficulty in the interpretation of IoU. In this study we 
chose to define intersection and union as all pixels of PNI in a slide as a single object. This 
did not consider relative sizes of PNI within a specific slide. For example, given a slide 
containing a large and a small PNI focus, one would obtain a higher IoU by fully detecting 
the large focus and fully failing to identify the small focus, rather than by partially detecting 
both foci. We would argue that the latter would still be more desirable when using the system 
as a diagnostic aid, but this is not captured by the IoU metric. Finally, we have not tested the 
algorithm on external data. We know from other studies involving whole slide images that 
one can expect some loss in performance on an external test set, likely due to differences in 
laboratory staining protocols, subjectivity in the assessment of pathology and potentially the 
use of different types of scanners to digitize the biopsy cores. To overcome these limitations, 
it is preferable to include a large sample in training the networks, specimens from different 
laboratories, a variety of types of image scanners and a wide range of prostate tumors 
showing differing morphologies. 
 
Neural networks have shown excellent results in the automation of the grading of cancers in 
prostate biopsies. An important limitation; however, is an inherent lack of flexibility. Networks 
only perform the task that they are trained on and do not reveal information relating to other 
findings. Moving towards a fully automated assessment of biopsies, we need networks that 
can address the interpretation of features additional to grading. All potential tasks do not 
need to be incorporated in a single network but can be implemented through several 
separate networks with each performing a single task. The evolving digital revolution of 
pathology will undoubtedly give rise to abundant data that can be utilized for training such 
specific networks. 
Conclusion 
This study has demonstrated that deep neural networks can screen appropriately for 
perineural invasion by cancer in prostate biopsies. This has the potential to reduce the 
workload for pathologists. Application of such systems will also allow for automatic 
interpretation of large datasets, which can be utilized to increase knowledge as to the 
reasons for the relationship between perineural invasion by prostate cancer and poor patient 
outcome. 
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Figure 1: Patient flow diagram. 
 
 
Table 1: (top) Patient characteristics. There were 11 patients (8 of 266 PNI positive men) on 
whom we could not retrieve clinical information. (bottom) Slide characteristics. There was 
no missing information. † The values in parentheses are the Gleason scores. 
 
 
Figure 2: Performance of the network to discriminate between PNI and non-PNI in individual 
cores (orange) and in subjects (blue). The curves are based on n=1,758 (n=106 positive) 
cores and n=286 (n=52 positive) subjects. The values in parentheses are confidence 
intervals. 
 
 
Table 2: Diagnostic metrics for the network. The operating points are alternative thresholds 
for positivity. The point marked (index test) is the value on which the algorithm is intended to 
be used, and the other three show the diagnostic properties of the model if a different 
sensitivity to specificity relationship is preferred. PPV = Positive Predictive Value, NPV = 
Negative Predictive Value.  
 
Figure 3: Illustration of PNI segmentation on the biopsy core with IoU (0.51) closest to the 
overall mean IoU (0.50) reported. The H&E stained biopsy (right) and the corresponding 
predicted pixel-wise classification and ground truth (middle), and two highlighted regions 
(left) are shown. The regions both annotated by the pathologist and classified as positive by 
the network (i.e. the intersection) is colored blue, and the regions not annotated but still 
classified positive by the network are yellow. In this example there were no regions 
annotated but not classified as positive. All pixels positive by either the pathologist or the 
network form the union (i.e. the denominator in the IoU). 
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Appendix 1: Data acquisition 
We used the STHLM3 register to select subjects whose biopsies we digitized. The first 500 
men who were diagnosed in the STHLM3 trial were selected. This contributed the majority of 
slides, n=5,662. Since it was a screening-by-invitation trial, there were relatively few high-
grade cases in this selection. To increase the coverage of the more rare high-grade cases and 
their associated morphologies, we included all subjects (their positive cores and a randomly 
selected negative core) with at least one core graded as Gleason Score (GS) 4+4 or 5+5, and 
a random selection of 497 subjects with at least one core graded 3+3. To increase the sample 
diversity of benign prostate tissue, we included 139 randomly selected cancer-free subjects 
from which we included one randomly selected core each. At this stage we had selected 1,289 
participants from which we retrieved 8,571 biopsy cores.  Finally, we included all cores in the 
STHLM3 register which had PNI reported which concluded a total of 8,803 slides from 1,427 
subjects. In some of these, the study pathologist did not manage to reproduce the PNI finding. 
This could be due to difficult to judge cases or the difference of using microscopy (the original 
assessment) and digital pathology (the annotation of PNI for this study). These slides were 
included as negative cases. 
 
The study pathologist (L.E.) subsequently highlighted each lesion of PNI pixel-wise in the 
digitized cores that were reported to contain PNI. This was done in the open source pathology 
software QuPath.1 From these annotations we created binary masks, i.e. images indicating 
the presence or absence of PNI for each pixel of the associated whole slide images. The 
binary masks acted as pixel-wise ground truth labels when training and evaluating the 
networks.  
 
There were two types of scanners used for digitizing the slides: Hamamatsu C9600-12 
scanner running NDP.scan software v. 2.5.86 (Hamamatsu Photonics, Hamamatsu, Japan) 
and Aperio ScanScope AT2 scanner running Aperio Image Library v. 12.0.15 software (Leica 
Biosystems, Wetzlar, Germany). At full-resolution (20X) the pixel sizes were 0.45202 µm 
(Hamamatsu) and 0.5032 µm (Aperio). The RGB images were stored at 8-bits per channel in 
NDPI (Hamamatsu) and SVS (Aperio) format. 
 
Appendix 2: Pre-processing 
The scanned images typically contain two consecutive sections from a single biopsy core. The 
annotation of PNI was done on one of these two sections arbitrarily chosen by the study 
pathologist. To only include the annotated section in the training, we semi-automatically 
removed the unannotated one. In the cases where the annotated section was located in its 
entirety within one half of the image, and the unannotated section within the other half, we 
retained the image half containing the annotated section. Otherwise, removal of the 
unannotated section was performed manually. 
 
Images were downsampled by a factor of 16 and converted from RGB to grayscale in 
accordance with the NTSC standard by calculating the weighted sum 0.2989 x R + 0.5870 x 
G + 0.1140 x B for each pixel. The tissue was segmented using Laplacian filtering, followed 
by thresholding the absolute magnitude of the resulting response using Otsu’s method.2 This 
resulted in binary masks indicating the tissue regions. For further details see Supplementary 
of Ström et al.3 
 
To create label masks, that is, masks with values 0 for background, 1 for non-PNI tissue, and 
2 for PNI, we exported binary masks from QuPath for each unique region annotated by the 
pathologist. We also stored the pixel coordinates from which they were extracted. Finally, we 
removed the complementary section in the mask as described above. 
 
Appendix 3: Neural Networks 
Patch extraction 
For classification, we cropped patches with dimensions of 598 x 598 pixels at the highest 
resolution (20X) of the whole slide images, corresponding to roughly 300 µm x 300 µm. The 
patches were then labeled as PNI positive if they contained at least one pixel of PNI based on 
the binary masks. 
 
For segmentation, we only used the slides positive for PNI and cropped patches of size 512 x 
512 pixels at 20X from them, corresponding to 250 µm x 250 µm. The reason for using a 
different patch size than for classification was to match the different network architectures’ 
default input sizes by factors of 2. In addition to cropping the tissue, we also cropped the 
corresponding region from the binary mask. These patches of the masks acted as the target 
variable when training the model for pixel-wise segmentation of PNI. 
 
Since most parts of the image are background, we only considered patches with at least half 
of the pixels containing tissue according to the tissue mask. Patches were systematically 
cropped from all parts of the whole slide images containing tissue, with 50% overlap between 
adjacent patches. Finally, the patches were stored on disk as .jpg using JPEG compression 
with 80% quality.  
Classification network 
The deep neural network (DNN) used for classification of PNI on the patch level was Xception.4 
Ten models were trained in an identical way (except for randomization in initiating the model 
weights and the sampling and sample order of patches), and an average of these models’ 
predictions was used as the final patch level prediction. For slide-level prediction, the 
maximum over the predictions of all patches from a slide was taken to represent the entire 
slide. Similarly, slide-level predictions were aggregated into subject-level predictions by taking 
the maximum over all slides from a given subject.  
 
For training the DNNs we used a batch size of 8, randomly initiated weights, partial class 
balancing via oversampling of the rare positive class (2 benign patches sampled per one 
positive patch) to counter the extreme class imbalance of the data, binary crossentropy loss, 
Adam as optimizer with learning rate 0.001 and with other parameters set to default values, 
and trained for 100 epochs.5 We augmented the data with random horizontal flips and random 
rotations of 90, 180, and 270 degrees.  
Segmentation network 
For segmentation we applied Unet on the patches.6 Similarly to the classification models, we 
used an ensemble of 10 DNNs. The prediction patches (i.e. pixel-wise predictions for PNI for 
an image patch) were mapped to their original positions in the image to produce a prediction 
image corresponding to each whole slide image. A threshold was used to generate a binary 
version of the prediction image. 
 
For training the DNNs we used a batch size of 8, randomly initiated weights, partial class 
balancing via oversampling of the rare positive class (4 benign patches sampled per one 
positive patch) to counter the extreme class imbalance of the data, Adam as optimizer with a 
learning rate of 0.0001 and other parameters set to default values, focal binary loss and trained 
for 20 epochs.7 We augmented the data with random horizontal flips and random rotations of 
90, 180, and 270 degrees. Pixel-wise probabilities were averaged across the models in the 
ensemble and scaled from a floating-point range of [0, 1] to an unsigned 8-bit integer range of 
[0, 255]) to store the information as heatmap images. Finally, a pre-specified threshold of 75 
was used to classify each pixel as positive. The reason that this was lower than a 
corresponding probability of 0.5 was to err on the side of sensitivity rather than specificity, 
since we argue that it is better to highlight additional potential foci rather than too few in the 
case of pixel-wise visualization. 
 
Hardware and software 
Computations were performed on a graphics processing unit (GPU) cluster (Tampere Center 
for Scientific Computing, Tampere, Finland) equipped with 28 x Tesla V100 and 32 x Tesla 
P100 GPUs (Nvidia, Santa Clara, CA, USA) distributed on 15 nodes. The GPUs were running 
Nvidia driver 440.64, CUDA 10.0.130 and cuDNN 7.6.0. The nodes were equipped with either 
a 20-core Xeon E5-2640 v4 or a 24-core Xeon Silver 4116 CPU (Intel, Santa Clara, CA, USA) 
and 254 GB, 385 GB or 785 GB of RAM. Each node was equipped with a local SSD disk. We 
used 32-bit floating point precision for GPU computation. 
 
We used OpenSlide (v. 3.4.1) via the Python interface (v. 1.1.1) to access the images.8 
MATLAB R2017b (The MathWorks, Natick, MA, USA) and python were used to create the 
necessary masks for pixel-wise labeling of tissue and PNI. DNNs were implemented in Python 
3.6.4 and TensorFlow (v 2.0.0).9 
 
Appendix 4: Complementary results 
We evaluated a number of design choices on training data. The evaluation was performed on 
a fixed validation split of 20% of the training data, using the remaining data for training. The 
split was performed on subject level. 
 
For classification we compared several DNN architectures: Inception V3, Xception, ResNet, 
InceptionResNetV2, NASNet, EfficentNet (B7)10–15 Of these, Inception V3 and Xception 
generally had the best performance across various hyperparameter settings and appeared 
most reliable in terms of few severe drops in performance (data not shown). Xception exhibited 
slightly better performance than Inception V3. A comparison between the two architectures is 
shown in Figure S1. 
 
Moreover, we evaluated several patch sizes and resolution combinations (see three well 
performing combinations in Figure S1). In addition, we evaluated different strides for extracting 
patches and observed that a stride of 299 pixels (that is, 50% overlap between patches of 598 
x 598 pixels), was superior to a stride of 150 pixels (data not shown).  
 
For segmentation, we compared several backbones for Unet: VGG16, ResNet, ResNeXt, 
Inceptionv3, and EfficientNet (B7).16 Inception V3 was chosen based on consistent high 
performance on various sampling strategies and learning rates (data not shown). We also 
compared several loss functions (see Figure S2 and S3). 
 
 
 
 
Figure S1: AUC for PNI classification using different patch sizes (598 and 1196 pixels), 
resolution (20X and 10X), and architecture (Inception V3 and Xception). From top: slide level, 
subject level, and patch level. 
 
 
Figure S2: Intersection over union on patch level for various loss functions. (First row; from 
left) binary focal Jaccard loss, binary crossentropy, and Jaccard loss. (Second row; from 
left) binary focal dice loss, dice loss, and binary focal loss. The x-axis is number of epochs. 
 
 
Figure S3: Accuracy on patch level for various loss functions. (First row; from left) binary 
focal Jaccard loss, binary crossentropy, and Jaccard loss. (Second row; from left) binary 
focal dice loss, dice loss, and binary focal loss. The x-axis is number of epochs. 
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